Prolonged or recurrent acute seizures after pediatric arterial ischemic stroke are associated with increasing

Christine K Fox1,2, Mark T Mackay3,4, Michael M Dowling5,6

  • 1Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Insights

Pediatric stroke survivors face a high risk of epilepsy, particularly younger children. Prolonged or recurrent acute seizures significantly increase this risk in a dose-dependent manner.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Epileptology

Background:

  • Pediatric stroke is a significant cause of acquired brain injury in children.
  • Epilepsy is a common complication following pediatric stroke, impacting long-term outcomes.
  • Identifying risk factors for epilepsy post-stroke is crucial for timely intervention.

Purpose of the Study:

  • To investigate the incidence and predictors of epilepsy in children following arterial ischemic stroke.
  • To determine the relationship between acute seizure characteristics and the development of active epilepsy within one year.

Main Methods:

  • A prospective cohort study involving 114 children (birth-18 years) with arterial ischemic stroke across 21 centers.
  • Patients were followed for one year to identify acute seizures (within 7 days) and active epilepsy (unprovoked remote seizures with anticonvulsant maintenance at 1 year).
  • Logistic regression analysis was used to identify predictors of epilepsy.

Main Results:

  • Among 109 patients with 1-year follow-up, 10% developed active epilepsy.
  • Younger age at stroke onset was associated with a higher risk of epilepsy (OR 0.8 per year younger).
  • Prolonged ( >5 minutes) or recurrent acute seizures significantly increased epilepsy risk, with >10 acute seizures conferring a 30-fold increased risk (OR 30).

Conclusions:

  • Pediatric stroke survivors, especially neonates and young children, are at high risk for developing epilepsy.
  • The frequency and duration of acute seizures following stroke are critical dose-dependent predictors of subsequent epilepsy.
  • Early identification and management of acute seizures may be vital in mitigating epilepsy risk in pediatric stroke survivors.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K